Literature DB >> 22078455

Characterization of a naturally occurring degradation product of the LDL receptor.

Kristian Tveten1, Thea Bismo Strøm, Jamie Cameron, Øystein L Holla, Knut Erik Berge, Trond P Leren.   

Abstract

In this study we have characterized a naturally occurring truncated form of the low density lipoprotein receptor (LDLR). Western blot analysis of transfected cells indicated that the truncated form (∆N-LDLR) is a degradation product of the full-length LDLR generated by cleavage in the linker region between ligand-binding repeats 4 and 5 of the ligand-binding domain. The cleavage of the linker was not caused by components of the culture media, as heat inactivation of the media did not prevent cleavage. Rather, it is assumed that cleavage was caused by an enzyme secreted from the cells. Biotinylation experiments showed that ∆N-LDLR is located on the cell surface and is detectable approximately 5 h after synthesis of the full-length LDLR. Flow cytometric analysis showed that ∆N-LDLR was not able to bind and internalize low density lipoprotein (LDL). ∆N-LDLR appeared to be equally stable as the full-length LDLR. Thus, generation of ∆N-LDLR does not appear to be the first signal for degradation of the LDLR. The existence of two functionally different populations of LDLRs on the cell surface, of which ∆N-LDLR constitutes 28%, must be taken into account when interpreting results of experiments to study LDLRs on the cell surface. Furthermore, if the cleavage of the linker between ligand-binding repeats 4 and 5 could be prevented by an enzyme inhibitor, this could represent a novel therapeutic strategy to increase the number of functioning LDLRs and thereby decrease the levels of plasma LDL cholesterol.
Copyright © 2011. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22078455     DOI: 10.1016/j.ymgme.2011.10.008

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  5 in total

Review 1.  Sudden infant death syndrome caused by cardiac arrhythmias: only a matter of genes encoding ion channels?

Authors:  Georgia Sarquella-Brugada; Oscar Campuzano; Sergi Cesar; Anna Iglesias; Anna Fernandez; Josep Brugada; Ramon Brugada
Journal:  Int J Legal Med       Date:  2016-02-12       Impact factor: 2.686

2.  PCSK9-mediated degradation of the LDL receptor generates a 17 kDa C-terminal LDL receptor fragment.

Authors:  Kristian Tveten; Thea Bismo Str M; Knut Erik Berge; Trond P Leren
Journal:  J Lipid Res       Date:  2013-03-18       Impact factor: 5.922

Review 3.  The Multifaceted Biology of PCSK9.

Authors:  Nabil G Seidah; Annik Prat
Journal:  Endocr Rev       Date:  2022-05-12       Impact factor: 25.261

4.  Mutation G805R in the transmembrane domain of the LDL receptor gene causes familial hypercholesterolemia by inducing ectodomain cleavage of the LDL receptor in the endoplasmic reticulum.

Authors:  Thea Bismo Strøm; Kristian Tveten; Jon K Laerdahl; Trond P Leren
Journal:  FEBS Open Bio       Date:  2014-03-19       Impact factor: 2.693

5.  Proteolysis of the low density lipoprotein receptor by bone morphogenetic protein-1 regulates cellular cholesterol uptake.

Authors:  Sreemoti Banerjee; Robert J Andrew; Christopher J Duff; Kate Fisher; Carolyn D Jackson; Catherine B Lawrence; Nobuyo Maeda; Daniel S Greenspan; Katherine A B Kellett; Nigel M Hooper
Journal:  Sci Rep       Date:  2019-08-06       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.